scispace - formally typeset
H

Huiling Wang

Researcher at Guangxi Medical University

Publications -  8
Citations -  94

Huiling Wang is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: Immunotherapy & Immune system. The author has an hindex of 5, co-authored 7 publications receiving 55 citations.

Papers
More filters
Journal ArticleDOI

A novel label-free terbium( iii )-aptamer based aptasensor for ultrasensitive and highly specific detection of acute lymphoma leukemia cells

TL;DR: A single-stranded DNA-sensitized terbium(iii) luminescence method diagnostic was developed which is rapid, sensitive, and economical and can be used for diagnosis of various types of leukemia at the early stage.
Journal ArticleDOI

Generation of Cancer-Specific Cytotoxic PD-1- T Cells Using Liposome-Encapsulated CRISPR/Cas System with Dendritic/Tumor Fusion Cells.

TL;DR: Liposome-encapsulated CRISPR/Cas9 genome editing technology effectively knocked out PD-1 gene in T cells, stimulating T cell activation in response to DC/tumor FCs and affording T cell-mediated cancer immunotherapy.
Journal ArticleDOI

PEGylated immunoliposome-loaded endoglin single-chain antibody enhances anti-tumor capacity of porcine α1,3GT gene.

TL;DR: The findings establish an alternative therapeutic paradigm for scFv-conjugated nanoparticles to induce tumor cell apoptosis and inhibit tumor growth early and believe that these scFV-targeted core-shell immunocomplexes are an important potential α1,3 GT delivery system for various solid tumor- targeted therapy.
Journal ArticleDOI

A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection

TL;DR: A dual-targeting magnetic nanoprobe with high-purity LECs from tumor tissues was successfully developed, providing a basis for clinical application of L ECs in colorectal cancer treatment as well as in early clinical diagnosis using bimodal imaging.